Oral Therapies in Oncology: Cognitive Function and Compliance
The investigators propose to evaluate the compliance of oral cancer therapies, particularly
the possible link between this observance and cognitive function of patients at initiation
of treatment. To our knowledge, this study will be among the first conducted on the issue in
France and is an innovative approach in the management of cancer patients. The inclusion of
cognitive dysfunction is part of a comprehensive approach to improving the quality of life
and fully meets the objectives of both plans cancer, including those of the axis "Living
during and after cancer" highlighted in the Cancer Plan
Clinical Trial Conditions: Oral Therapies, Cancer, Cognitive Function, Compliance
Eligible Clinical Trial Participant Age : Between 18 years to 100 years
Can Healthy Volunteers Participate: No
Clinical Trial Lead Sponsor: Centre Francois Baclesse
Detailed Clinical Trial Description: The investigators propose to evaluate the compliance of oral cancer therapies, particularly
the possible link between this observance and cognitive function of patients at initiation
of treatment. To our knowledge, this study will be among the first conducted on the issue in
France and is an innovative approach in the management of cancer patients. The inclusion of
cognitive dysfunction is part of a comprehensive approach to improving the quality of life
and fully meets the objectives of both plans cancer, including those of the axis "Living
during and after cancer" highlighted in the Cancer Plan
The clinical trial information was obtained from http://clinicaltrials.gov/ct2/show/NCT01597284
